Eugene Gusev

981 total citations
30 papers, 561 citations indexed

About

Eugene Gusev is a scholar working on Neurology, Neurology and Epidemiology. According to data from OpenAlex, Eugene Gusev has authored 30 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 5 papers in Neurology and 5 papers in Epidemiology. Recurrent topics in Eugene Gusev's work include Neurological Disorders and Treatments (13 papers), Neurological Disease Mechanisms and Treatments (9 papers) and Acute Ischemic Stroke Management (4 papers). Eugene Gusev is often cited by papers focused on Neurological Disorders and Treatments (13 papers), Neurological Disease Mechanisms and Treatments (9 papers) and Acute Ischemic Stroke Management (4 papers). Eugene Gusev collaborates with scholars based in Russia, Germany and Romania. Eugene Gusev's co-authors include Alla Guekht, Richard Dodel, Jens Peter Reese, Yaroslav Winter, В. И. Скворцова, А. Н. Бойко, Ovidiu Băjenaru, Wolf‐Dieter Heiss, Johannes Vester and Dafin F. Mureșanu and has published in prestigious journals such as Movement Disorders, Journal of the Neurological Sciences and Journal of Neuroimmunology.

In The Last Decade

Eugene Gusev

27 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugene Gusev Russia 14 202 196 126 82 73 30 561
Е. И. Гусев Russia 14 142 0.7× 102 0.5× 79 0.6× 87 1.1× 145 2.0× 67 550
Yoshio Omote Japan 15 146 0.7× 152 0.8× 97 0.8× 77 0.9× 52 0.7× 61 576
Masayasu Takahashi Japan 15 102 0.5× 99 0.5× 117 0.9× 68 0.8× 40 0.5× 43 663
Friederike Ufer Germany 13 145 0.7× 299 1.5× 57 0.5× 45 0.5× 123 1.7× 24 877
S. Gauthier France 14 58 0.3× 124 0.6× 25 0.2× 164 2.0× 112 1.5× 37 604
Demetrios Vassilopoulos Greece 14 81 0.4× 236 1.2× 108 0.9× 80 1.0× 57 0.8× 23 658
Christine E. Stahl United States 13 96 0.5× 170 0.9× 90 0.7× 27 0.3× 22 0.3× 19 595
Qinghua Wang China 13 184 0.9× 405 2.1× 63 0.5× 39 0.5× 46 0.6× 29 796

Countries citing papers authored by Eugene Gusev

Since Specialization
Citations

This map shows the geographic impact of Eugene Gusev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Gusev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Gusev more than expected).

Fields of papers citing papers by Eugene Gusev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene Gusev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Gusev. The network helps show where Eugene Gusev may publish in the future.

Co-authorship network of co-authors of Eugene Gusev

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene Gusev. A scholar is included among the top collaborators of Eugene Gusev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene Gusev. Eugene Gusev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gusev, Eugene, M. Yu. Martynov, I. A. Voznyuk, et al.. (2021). The Novel Coronavirus Infection (COVID-19) and Nervous System Involvement: Mechanisms of Neurological Disorders, Clinical Manifestations, and the Organization of Neurological Care. Neuroscience and Behavioral Physiology. 51(2). 147–154. 7 indexed citations
2.
Gusev, Eugene, M. Yu. Martynov, I. A. Voznyuk, et al.. (2020). Novel coronavirus infection (COVID-19) and nervous system involvement: pathogenesis, clinical manifestations, organization of neurological care. S S Korsakov Journal of Neurology and Psychiatry. 120(6). 7–7. 34 indexed citations
3.
Gusev, Eugene, et al.. (2019). Immunological predictors of acute post-stroke period. S S Korsakov Journal of Neurology and Psychiatry. 119(8). 39–39. 3 indexed citations
4.
Gusev, Eugene, et al.. (2018). The efficacy of semax in the tretament of patients at different stages of ischemic stroke. S S Korsakov Journal of Neurology and Psychiatry. 118(3). 61–61. 18 indexed citations
5.
Gusev, Eugene, et al.. (2018). Thrombolytic therapy of ischemic stroke. S S Korsakov Journal of Neurology and Psychiatry. 118(12). 4–4. 6 indexed citations
6.
Bornstein, Natan M., Alla Guekht, Johannes Vester, et al.. (2017). Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials. Neurological Sciences. 39(4). 629–640. 81 indexed citations
7.
Guekht, Alla, Johannes Vester, Wolf‐Dieter Heiss, et al.. (2017). Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials. Neurological Sciences. 38(10). 1761–1769. 39 indexed citations
8.
Martynov, M. Yu., et al.. (2015). Characteristics of risk factors in young and middle-aged patients with first hemispheric ischemic stroke. S S Korsakov Journal of Neurology and Psychiatry. 115(12. Vyp. 2). 13–13. 3 indexed citations
9.
Torshin, I. Yu., et al.. (2011). [International experience in studying effects of omega-3 polyunsaturated fatty acids: the influence on cognitive abilities and some mental disorders].. PubMed. 111(11 Pt 1). 79–86.
10.
Winter, Yaroslav, Е А Катунина, Jens Peter Reese, et al.. (2010). Incidence of Parkinson's disease and atypical parkinsonism: Russian population‐based study. Movement Disorders. 25(3). 349–356. 58 indexed citations
11.
Guekht, Alla, et al.. (2010). The epidemiology of epilepsy in the Russian Federation. Epilepsy Research. 92(2-3). 209–218. 52 indexed citations
12.
Winter, Yaroslav, Sonja von Campenhausen, Jens Peter Reese, et al.. (2009). Social and clinical determinants of quality of life in Parkinson's disease in a Russian cohort study. Parkinsonism & Related Disorders. 16(4). 243–248. 43 indexed citations
13.
Parfenov, Michael, М. А. Судомоина, С.А. Федорова, et al.. (2007). Polymorphism of apolipoprotein E (APOE) and lipoprotein lipase (LPL) genes and ischaemic stroke in individuals of Yakut ethnicity. Journal of the Neurological Sciences. 255(1-2). 42–49. 22 indexed citations
14.
Бойко, А. Н., et al.. (2003). [Mechanisms of development of neurodegenerative processes in multiple sclerosis: neuroprotective influence of beta-interferons today and neurotrophic factors -- tomorrow].. PubMed. 83–90. 2 indexed citations
15.
Gusev, Eugene & В. И. Скворцова. (2003). Brain Ischemia. 11 indexed citations
16.
Скворцова, В. И., et al.. (2000). Levels of neurotransmitter amino acids in the cerebrospinal fluid of patients with acute ischemic insult. Neuroscience and Behavioral Physiology. 30(5). 491–495. 16 indexed citations
17.
Gusev, Eugene, et al.. (1999). [Neuroprotective effects of glycine in the acute period of ischemic stroke].. PubMed. 99(2). 12–20. 4 indexed citations
18.
Gusev, Eugene, et al.. (1996). Environmental risk factors in MS: a case-control study in Moscow. Acta Neurologica Scandinavica. 94(6). 386–394. 41 indexed citations
19.
Бойко, А. Н., et al.. (1995). Epidemiology of multiple sclerosis in Russia and other countries of the former Soviet Union: investigations of environmental and genetic factors. Acta Neurologica Scandinavica. 91(S161). 71–76. 20 indexed citations
20.
Бойко, А. Н., et al.. (1995). Results of a case-control study of multiple sclerosis in Moscow points to the importance of nutrition in childhood. Journal of Neuroimmunology. 56-63. 58–58.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026